Sea Crest Wealth Management, LLC Myriad Genetics Inc Transaction History

Sea Crest Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$12.16 - $19.77 $178,448 - $290,124	-14,675 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$11.25 - $14.75 $165,093 - $216,456	14,675 New	14,675 $191,000
Q2 2019 Jul 19, 2019	SELL	$22.67 - $35.0 $14,735 - $22,750	-650 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$26.93 - $34.7 $9,425 - $12,145	350 Added 116.67%	650 $22,000
Q4 2017 Feb 02, 2018	BUY	$28.45 - $37.14 $8,535 - $11,142	300	300 $10,000

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.23B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.